Generic Drug Cluster: What Are Global Regulators Discussing?
FDA’s Sarah Ibrahim Outlined Key Generic Drug Topics Among Seven Health Agencies
In its ongoing attempt to embrace international harmonization, the US Food and Drug Administration invited stakeholders from both sides of the Atlantic to discuss how global health regulators can join forces to improve generic drug development at a recent webinar on “Expanding Generic Drug Access Through International Engagements.”
